Matrix Metalloproteinase 3
"Matrix Metalloproteinase 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extracellular endopeptidase of vertebrate tissues similar to MATRIX METALLOPROTEINASE 1. It digests PROTEOGLYCAN; FIBRONECTIN; COLLAGEN types III, IV, V, and IX, and activates procollagenase. (Enzyme Nomenclature, 1992)
| Descriptor ID |
D019278
|
| MeSH Number(s) |
D08.811.277.656.300.480.525.700.200 D08.811.277.656.675.374.525.700.200 D12.644.276.848.200 D12.776.467.836.200
|
| Concept/Terms |
Matrix Metalloproteinase 3- Matrix Metalloproteinase 3
- Metalloproteinase 3, Matrix
- Transin
- MMP3 Metalloproteinase
- Metalloproteinase, MMP3
- Stromelysin 1
- MMP-3 Metalloproteinase
- MMP 3 Metalloproteinase
- Metalloproteinase, MMP-3
- Stromelysin
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 3".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 3".
This graph shows the total number of publications written about "Matrix Metalloproteinase 3" by people in this website by year, and whether "Matrix Metalloproteinase 3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 3" by people in Profiles.
-
Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells. Mol Vis. 2014; 20:1243-52.
-
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. PLoS One. 2013; 8(4):e62023.
-
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. 2009 May; 2(3):243-53.
-
Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis? J Neuroinflammation. 2008 Jan 03; 5:1.
-
TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Exp Eye Res. 2004 Aug; 79(2):263-74.
-
Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003 Jul; 44(7):2928-36.
-
Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol. 2001 Jan; 119(1):71-80.
-
Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci. 2000 Sep; 41(10):2922-9.
-
Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2000 Jul; 41(8):2154-63.
-
Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci. 2000 Feb; 41(2):404-10.